Abstract
At this time, the data available on tacrine are inconclusive with respect to efficacy. Preliminary data are often overinterpreted, and it seems prudent to wait for the results of the ongoing multicenter double-blind studies before reaching a definite conclusion about efficacy.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Alzheimer Disease / drug therapy*
-
Alzheimer Disease / metabolism
-
Aminoacridines / therapeutic use*
-
Cholinesterase Inhibitors / therapeutic use*
-
Clinical Trials as Topic
-
Double-Blind Method
-
Humans
-
Tacrine / therapeutic use*
Substances
-
Aminoacridines
-
Cholinesterase Inhibitors
-
Tacrine